CTRI/2022/11/047108尚未招募2 期
evofloxacin based therapy vs Hybrid therapy in the eradication of Helicobacter pylori: A randomized controlled trial.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- JIPMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •adult patients of age 18-80 years with peptic ulcer disease will be included
排除标准
- •1.Previous eradication therapy.
- •2.Patients who have used antibiotics within the previous 4 weeks.
- •3.Past history of developing allergy to any antibiotic used in the study.
- •4.Patients who have undergone gastrectomy.
- •5.Coexisting of severe concomitant illness.
- •6. Pregnancy or lactating women.
- •7.Patients diagnosed with any malignancies.
- •Patients with portal gastropathy.
研究者
相似试验
已完成
不适用
High-dose Levofloxacin in Community-acquired PneumoniaDiseases of th respiratory systemKCT0000374Ewha Womans University Medical Center40
已完成
3 期
Comparison between clarithromycin and levofloxacin in treatment of H pyloriDigestive SystemHelicobacter pyloriPACTR202012742050337Benha University Hospital200
已完成
不适用
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail patients with cardiovascular diseasefrail patients with cardiovascular diseaseJPRN-UMIN000034714Sakakibara Heart Institute90
已完成
不适用
Efficacy and safety of hybrid therapy combined with branched-chain amino acid and resistance training in frail CKD patients with cardiovascular diseasefrail CKD patients with cardiovascular diseaseJPRN-UMIN000034733Department of Rehabilitation, Sakakibara Heart institute90
尚未招募
不适用
To show that reverse Hybrid therapy is as efficacious in eradication of helicobacter pylori infection as concomitant therapy with fewer adverse events and better complianceCTRI/2021/11/038336JIPMER